Hepatitis B Birth Dose Vaccination among Vietnamese Children: Implications for the Expanded Program on Immunization

Biomed Res Int. 2019 Jun 16:2019:3453105. doi: 10.1155/2019/3453105. eCollection 2019.

Abstract

Background: This study assesses the prevalence of Vietnamese children receiving the hepatitis B (HepB) vaccine birth dose and explores its associated socioeconomic factors.

Methods: We used the data of the Multiple Indicator Cluster Survey, 2014. We estimated the overall percentage of HepB birth dose vaccination among 0-23-month-old children and its percentages according to selected characteristics. Multiple logistic regression was applied.

Results: 62.8% of children received the HepB vaccine birth dose. The prevalence rates by selected factors ranged from 35.3% to 76.7%. The categories with the lowest prevalence rates were children who had low birth weight (41.6%), had a mother aged less than 20 years (35.3%), had a mother with primary or less education (42.7%), belonged to ethnic minorities (30.3%), resided in rural areas (59.9%), and were in the 1st quintile of mother's socioeconomic status (38.6%). Receiving HepB vaccine birth dose was associated with child's birth weight, mother's age, mother's education, socioeconomic status, and ethnicity.

Conclusions: This study identified vulnerable groups, upon which policy-makers should focus their efforts to equitably and sustainably tackle birth dose HepB vaccine coverage as well as the full vaccination coverage, thereby promoting long-lasting herd immunity in this country.

MeSH terms

  • Adult
  • Dose-Response Relationship, Drug
  • Female
  • Hepatitis B / epidemiology
  • Hepatitis B / immunology
  • Hepatitis B / prevention & control*
  • Hepatitis B / virology
  • Hepatitis B Vaccines / immunology
  • Hepatitis B Vaccines / therapeutic use*
  • Humans
  • Immunization Programs*
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Mothers
  • Parturition / immunology
  • Pregnancy
  • Social Class
  • Vaccination
  • Vietnam / epidemiology

Substances

  • Hepatitis B Vaccines